The United Kingdom has identified a new coronavirus variant linked to a recent surge in cases in England. The new variant shows some mutations within the Spike protein (S-protein) as well as the NP protein. As scientists do more research to understand these mutations better, at the moment, CTK has no reason to believe that the mutations will affect the OnSite® COVID-19 Ag Rapid Test‘s performance.
Confirmation studies are in the works to ensure that the OnSite® COVID-19 Ag Rapid Test isn’t affected by these mutations. CTK is committed to developing quality products and educating our customers on new findings of the SARS-CoV-2 virus and how they may or may not affect our products.
To learn more about our OnSite® Ag Rapid Test, click here
SARS-CoV-2 variant confirmation studies update, click here